Skip to content

Enzymotec Ltd.

Delisted

CIK 1578809fmd_174A633Z61B592XKC0NNBB4GK2Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Jan 01, 2011 to Dec 31, 2016, 6 periods

Latest annual · FY2016

Millions
Total revenues
48
Gross profit
30
Operating income
(3)
Net income
(3)
Free cash flow
(1)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2013 to FY2016
-9.8%
Revenue, 5 yearsFY2011 to FY2016
+15.7%
Net income, 5 yearsFY2011 to FY2016
n/m

Enzymotec Ltd. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2016FY2015ChangeSource
Revenue$47.7 million$50.4 million-5.3%20-F 2017-03-16 · proof
Gross profit$30 million$30.8 million-2.5%20-F 2017-03-16 · proof
Operating income-$3.1 million$6.2 million-150.4%20-F 2017-03-16 · proof
Net income-$2.9 million$6.7 million-143.7%20-F 2017-03-16 · proof
Cash from operating activities$1.4 million$11.2 million-87.6%20-F 2017-03-16 · proof
Free cash flow-$729,000$8.3 million-108.8%20-F 2017-03-16 · proof
Total assets$146.9 million$148.9 million-1.3%20-F 2017-03-16 · proof
Total liabilities$10.3 million$12.2 million-15.2%20-F 2017-03-16 · proof
Cash and cash equivalents$7.6 million$22 million-65.5%20-F 2017-03-16 · proof
What was Enzymotec Ltd.'s revenue in fiscal 2016?
Enzymotec Ltd. reported revenue of $47.7 million for fiscal 2016 (the year ended Dec 31, 2016), against $50.4 million the year before (-5.3%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What was Enzymotec Ltd.'s gross profit in fiscal 2016?
Enzymotec Ltd. reported gross profit of $30 million for fiscal 2016 (the year ended Dec 31, 2016), against $30.8 million the year before (-2.5%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What was Enzymotec Ltd.'s operating income in fiscal 2016?
Enzymotec Ltd. reported operating income of -$3.1 million for fiscal 2016 (the year ended Dec 31, 2016), against $6.2 million the year before (-150.4%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What was Enzymotec Ltd.'s net income in fiscal 2016?
Enzymotec Ltd. reported net income of -$2.9 million for fiscal 2016 (the year ended Dec 31, 2016), against $6.7 million the year before (-143.7%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What was Enzymotec Ltd.'s cash from operating activities in fiscal 2016?
Enzymotec Ltd. reported cash from operating activities of $1.4 million for fiscal 2016 (the year ended Dec 31, 2016), against $11.2 million the year before (-87.6%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What was Enzymotec Ltd.'s free cash flow in fiscal 2016?
Enzymotec Ltd. reported free cash flow of -$729,000 for fiscal 2016 (the year ended Dec 31, 2016), against $8.3 million the year before (-108.8%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What are Enzymotec Ltd.'s total assets?
As of Dec 31, 2016, Enzymotec Ltd. reported total assets of $146.9 million, against $148.9 million a year earlier (-1.3%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What are Enzymotec Ltd.'s total liabilities?
As of Dec 31, 2016, Enzymotec Ltd. reported total liabilities of $10.3 million, against $12.2 million a year earlier (-15.2%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC
What are Enzymotec Ltd.'s cash and cash equivalents?
As of Dec 31, 2016, Enzymotec Ltd. reported cash and cash equivalents of $7.6 million, against $22 million a year earlier (-65.5%). Source: the 20-F filed with the SEC on Mar 16, 2017. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1578809&period_type=annual&limit=5"

Information only, not investment advice.